Literature DB >> 20646763

CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity.

Gisela M Vaitaitis1, David H Wagner.   

Abstract

The CD40-CD154 dyad is an intensely studied field as is glycosylation status and both impact immunological functions and autoimmune conditions. CD40 has several isoforms, is modified by glycosylation, and trimerizes to form the functional receptor. We described a CD4(+)CD40(+) T cell (Th40) subset which is expanded in autoimmunity and is necessary and sufficient in transferring type 1 diabetes. Glycosylation impacts immunological events and T cells from autoimmune mouse strains express 30-40% less GlcNAc-branched N-glycans than T cells from non-autoimmune strains, a decrease known to activate T cells. Here we demonstrate that several CD40 receptor constellations exist on CD4 T cells. However, rather than containing different isoforms of CD40 they contain different glycoforms of isoform I. The glycoform profile is dependent on availability of CD154 and autoimmune NOD mice express a high level of a less glycosylated form. Interestingly, CD40 stimulation induces some CD40 receptor constellations that contain TNF-receptors 1 and 2 and targeting of those alters CD40 signaling outcomes in NOD Th40 cells. CD40-stimulation in vivo of non-autoimmune BALB/c mice expands the Th40 population and alters the CD40 glycoform profile of those cells to appear more like that of autoimmune prone NOD mice. Further understanding the dynamics and composition of the different CD40 receptor constellations will provide important insights into treatment options in autoimmunity. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20646763      PMCID: PMC2918662          DOI: 10.1016/j.molimm.2010.05.288

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  43 in total

1.  A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells.

Authors:  R J Noelle; M Roy; D M Shepherd; I Stamenkovic; J A Ledbetter; A Aruffo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

Review 2.  TRAF proteins in CD40 signaling.

Authors:  Gail A Bishop; Carissa R Moore; Ping Xie; Laura L Stunz; Zachary J Kraus
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

Review 3.  Role of CD40-CD40-ligand interaction in Ig-isotype switching.

Authors:  R Fuleihan; N Ramesh; R S Geha
Journal:  Curr Opin Immunol       Date:  1993-12       Impact factor: 7.486

4.  Biochemical characteristics and partial amino acid sequence of the receptor-like human B cell and carcinoma antigen CDw40.

Authors:  S Braesch-Andersen; S Paulie; H Koho; H Nika; P Aspenström; P Perlmann
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

5.  Cutting edge: CD40-induced expression of recombination activating gene (RAG) 1 and RAG2: a mechanism for the generation of autoaggressive T cells in the periphery.

Authors:  Gisela M Vaitaitis; Michelle Poulin; Richard J Sanderson; Kathryn Haskins; David H Wagner
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

6.  Upregulation of CD40--CD40 ligand system in patients with diabetes mellitus.

Authors:  Yan Jinchuan; Wu Zonggui; Chen Jinming; Li Li; Kong Xiantao
Journal:  Clin Chim Acta       Date:  2004-01       Impact factor: 3.786

7.  Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40.

Authors:  F H Durie; R A Fava; T M Foy; A Aruffo; J A Ledbetter; R J Noelle
Journal:  Science       Date:  1993-09-03       Impact factor: 47.728

8.  Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitus.

Authors:  Dan M Waid; Gisela M Vaitaitis; David H Wagner
Journal:  Eur J Immunol       Date:  2004-05       Impact factor: 5.532

9.  CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration.

Authors:  Jon D Vogel; Gail A West; Silvio Danese; Carol De La Motte; Manijeh H Phillips; Scott A Strong; Joseph Willis; Claudio Fiocchi
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

10.  Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis.

Authors:  Sergio A Quezada; Maria Eckert; Oyedele A Adeyi; Alan R Schned; Randolph J Noelle; Christopher M Burns
Journal:  Arthritis Rheum       Date:  2003-09
View more
  14 in total

Review 1.  Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).

Authors:  D H Wagner
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

2.  A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis.

Authors:  Gisela M Vaitaitis; Martin G Yussman; David H Wagner
Journal:  J Neuroimmunol       Date:  2019-03-21       Impact factor: 3.478

3.  CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter].

Authors:  Gisela M Vaitaitis; Michael H Olmstead; Dan M Waid; Jessica R Carter; David H Wagner
Journal:  Diabetologia       Date:  2019-07-08       Impact factor: 10.122

4.  A Drosophila Tumor Suppressor Gene Prevents Tonic TNF Signaling through Receptor N-Glycosylation.

Authors:  Geert de Vreede; Holly A Morrison; Alexandra M Houser; Ryan M Boileau; Ditte Andersen; Julien Colombani; David Bilder
Journal:  Dev Cell       Date:  2018-06-04       Impact factor: 12.270

5.  CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.

Authors:  Gisela M Vaitaitis; Dan M Waid; Martin G Yussman; David H Wagner
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

6.  An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.

Authors:  Gisela M Vaitaitis; Jessica R Carter; Dan M Waid; Michael H Olmstead; David H Wagner
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

7.  Pro-inflammatory T-lymphocytes rapidly infiltrate into the brain and contribute to neuronal injury following cardiac arrest and cardiopulmonary resuscitation.

Authors:  Guiying Deng; Jessica Carter; Richard J Traystman; David H Wagner; Paco S Herson
Journal:  J Neuroimmunol       Date:  2014-07-22       Impact factor: 3.478

8.  A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.

Authors:  Gisela M Vaitaitis; Michael H Olmstead; Dan M Waid; Jessica R Carter; David H Wagner
Journal:  Diabetologia       Date:  2014-08-08       Impact factor: 10.122

9.  CD40 interacts directly with RAG1 and RAG2 in autoaggressive T cells and Fas prevents CD40-induced RAG expression.

Authors:  Gisela M Vaitaitis; David H Wagner
Journal:  Cell Mol Immunol       Date:  2013-09-16       Impact factor: 11.530

10.  Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.

Authors:  Dan M Waid; Teri Schreiner; Gisela Vaitaitis; Jessica R Carter; John R Corboy; David H Wagner
Journal:  J Neuroimmunol       Date:  2014-03-15       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.